Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2012

Open Access 01-12-2012 | Original investigation

Effect of vitamin D on aortic remodeling in streptozotocin-induced diabetes

Authors: Erik Salum, Priit Kampus, Mihkel Zilmer, Jaan Eha, Mark Butlin, Alberto P Avolio, Taavi Põdramägi, Andres Arend, Marina Aunapuu, Jaak Kals

Published in: Cardiovascular Diabetology | Issue 1/2012

Login to get access

Abstract

Background

Diabetes mellitus is associated with micro- and macrovascular complications and increased cardiovascular risk. Elevated levels of serum asymmetric dimethylarginine (ADMA) may be responsible for endothelial dysfunction associated with diabetes-induced vascular impairment. Vitamin D may have potential protective effects against arterial stiffening. This study aimed to examine both the effects of diabetes on the functional/structural properties of the aorta and the endothelial function and the effects of vitamin D supplementation.

Methods

Male Wistar rats (n = 30) were randomly assigned to control untreated, diabetic untreated, and diabetic + cholecalciferol groups. Diabetes was induced by intraperitoneal injection of streptozotocin, followed by oral administration of cholecalciferol (500 IU/kg) for 10 weeks in the treatment group. Aortic pulse wave velocity (PWV) was recorded over a mean arterial pressure (MAP) range of 50 to 200 mmHg using a dual pressure sensor catheter. Intravenous infusion of phenylephrine and nitroglycerine was used to increase and decrease MAP, respectively. Serum 25-hydroxyvitamin D [25(OH)D] levels were measured using a radioimmune assay. ADMA levels in serum were measured by enzyme-linked immunoassay. Aortic samples were collected for histomorphometrical analysis.

Results

PWV up to MAP 170 mmHg did not reveal any significant differences between all groups, but in diabetic rats, PWV was significantly elevated across MAP range between 170 and 200 mmHg. Isobaric PWV was similar between the treated and untreated diabetic groups, despite significant differences in the levels of serum 25(OH)D (493 ± 125 nmol/L vs 108 ± 38 nmol/L, respectively). Serum levels of ADMA were similarly increased in the treated and untreated diabetic groups, compared to the control group. The concentration and integrity of the elastic lamellae in the medial layer of the aorta was impaired in untreated diabetic rats and improved by vitamin D supplementation.

Conclusion

PWV profile determined under isobaric conditions demonstrated differential effects of uncontrolled diabetes on aortic stiffness. Diabetes was also associated with elevated serum levels of ADMA. Vitamin D supplementation did not improve the functional indices of aortic stiffness or endothelial function, but prevented the fragmentation of elastic fibers in the aortic media.
Appendix
Available only for authorised users
Literature
1.
go back to reference Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993, 16: 434-444. 10.2337/diacare.16.2.434.CrossRefPubMed Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993, 16: 434-444. 10.2337/diacare.16.2.434.CrossRefPubMed
2.
go back to reference Weber T, Auer J, O’Rourke MF, Kvas E, Lassnig E, Berent R, Eber B: Arterial stiffness, wave reflections, and the risk of coronary heart disease. Circulation. 2004, 109: 184-189. 10.1161/01.CIR.0000105767.94169.E3.CrossRefPubMed Weber T, Auer J, O’Rourke MF, Kvas E, Lassnig E, Berent R, Eber B: Arterial stiffness, wave reflections, and the risk of coronary heart disease. Circulation. 2004, 109: 184-189. 10.1161/01.CIR.0000105767.94169.E3.CrossRefPubMed
3.
go back to reference Roman MJ, Ganau A, Saba PS, Pini R, Pickering TG, Devereux RB: Impact of arterial stiffening on left ventricular structure. Hypertension. 2000, 36: 489-494. 10.1161/01.HYP.36.4.489.CrossRefPubMed Roman MJ, Ganau A, Saba PS, Pini R, Pickering TG, Devereux RB: Impact of arterial stiffening on left ventricular structure. Hypertension. 2000, 36: 489-494. 10.1161/01.HYP.36.4.489.CrossRefPubMed
4.
go back to reference Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG: Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function?. Circulation. 2002, 106: 2085-2090. 10.1161/01.CIR.0000033824.02722.F7.CrossRefPubMed Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG: Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function?. Circulation. 2002, 106: 2085-2090. 10.1161/01.CIR.0000033824.02722.F7.CrossRefPubMed
5.
go back to reference Vallance P, Leone A, Calver A, Collier J, Moncada S: Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J Cardiovasc Pharmacol. 1992, 20: S60-S62.CrossRefPubMed Vallance P, Leone A, Calver A, Collier J, Moncada S: Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J Cardiovasc Pharmacol. 1992, 20: S60-S62.CrossRefPubMed
6.
go back to reference Ito A, Tsao PS, Adimoolam S, Kimoto M, Ogawa T, Cooke JP: Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation. 1999, 99: 3092-3095. 10.1161/01.CIR.99.24.3092.CrossRefPubMed Ito A, Tsao PS, Adimoolam S, Kimoto M, Ogawa T, Cooke JP: Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation. 1999, 99: 3092-3095. 10.1161/01.CIR.99.24.3092.CrossRefPubMed
7.
go back to reference Böger RH, Bode-Böger SM, Szuba A, Tsao PS, Chan JR, Tangphao O, Blaschke TF, Cooke JP: Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation. 1998, 98: 1842-1847. 10.1161/01.CIR.98.18.1842.CrossRefPubMed Böger RH, Bode-Böger SM, Szuba A, Tsao PS, Chan JR, Tangphao O, Blaschke TF, Cooke JP: Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation. 1998, 98: 1842-1847. 10.1161/01.CIR.98.18.1842.CrossRefPubMed
8.
go back to reference Kals J, Kampus P, Kals M, Teesalu R, Zilmer K, Pulges A, Zilmer M: Arterial elasticity is associated with endothelial vasodilatory function and asymmetric dimethylarginine level in healthy subjects. Scand J Clin Lab Invest. 2007, 67: 536-544. 10.1080/00365510701203470.CrossRefPubMed Kals J, Kampus P, Kals M, Teesalu R, Zilmer K, Pulges A, Zilmer M: Arterial elasticity is associated with endothelial vasodilatory function and asymmetric dimethylarginine level in healthy subjects. Scand J Clin Lab Invest. 2007, 67: 536-544. 10.1080/00365510701203470.CrossRefPubMed
9.
go back to reference Jensen-Urstad KJ, Reichard PG, Rosfors JS, Lindblad LE, Jensen-Urstad MT: Early atherosclerosis is retarded by improved long-term blood glucose control in patients with IDDM. Diabetes. 1996, 45: 1253-1258. 10.2337/diabetes.45.9.1253.CrossRefPubMed Jensen-Urstad KJ, Reichard PG, Rosfors JS, Lindblad LE, Jensen-Urstad MT: Early atherosclerosis is retarded by improved long-term blood glucose control in patients with IDDM. Diabetes. 1996, 45: 1253-1258. 10.2337/diabetes.45.9.1253.CrossRefPubMed
10.
go back to reference Wang L, Manson JE, Song Y, Sesso HD: Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med. 2010, 152: 315-323.CrossRefPubMed Wang L, Manson JE, Song Y, Sesso HD: Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med. 2010, 152: 315-323.CrossRefPubMed
11.
go back to reference Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M, Vasan RS: Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008, 117: 503-511. 10.1161/CIRCULATIONAHA.107.706127.CrossRefPubMed Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M, Vasan RS: Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008, 117: 503-511. 10.1161/CIRCULATIONAHA.107.706127.CrossRefPubMed
12.
go back to reference Tarcin O, Yavuz DG, Ozben B, Telli A, Ogunc AV, Yuksel M, Toprak A, Yazici D, Sancak S, Deyneli O, Akalin S: Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab. 2009, 94: 4023-4030. 10.1210/jc.2008-1212.CrossRefPubMed Tarcin O, Yavuz DG, Ozben B, Telli A, Ogunc AV, Yuksel M, Toprak A, Yazici D, Sancak S, Deyneli O, Akalin S: Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab. 2009, 94: 4023-4030. 10.1210/jc.2008-1212.CrossRefPubMed
13.
go back to reference London GM, Guérin AP, Verbeke FH, Pannier B, Boutouyrie P, Marchais SJ, Mëtivier F: Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol. 2007, 18: 613-620. 10.1681/ASN.2006060573.CrossRefPubMed London GM, Guérin AP, Verbeke FH, Pannier B, Boutouyrie P, Marchais SJ, Mëtivier F: Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol. 2007, 18: 613-620. 10.1681/ASN.2006060573.CrossRefPubMed
14.
go back to reference Mayer O, Filipovský J, Seidlerová J, Vaněk J, Dolejšová M, Vrzalová J, Cífková R: The association between low 25-hydroxyvitamin D and increased aortic stiffness. J Hum Hypertens. 2011, doi:10.1038/jhh.2011.94. Mayer O, Filipovský J, Seidlerová J, Vaněk J, Dolejšová M, Vrzalová J, Cífková R: The association between low 25-hydroxyvitamin D and increased aortic stiffness. J Hum Hypertens. 2011, doi:10.1038/jhh.2011.94.
15.
go back to reference Rezai MR, Wallace AM, Sattar N, Finn JD, Wu FC, Cruickshank JK: Ethnic differences in aortic pulse wave velocity occur in the descending aorta and may be related to vitamin D. Hypertension. 2011, 58: 247-253. 10.1161/HYPERTENSIONAHA.111.174425.CrossRefPubMed Rezai MR, Wallace AM, Sattar N, Finn JD, Wu FC, Cruickshank JK: Ethnic differences in aortic pulse wave velocity occur in the descending aorta and may be related to vitamin D. Hypertension. 2011, 58: 247-253. 10.1161/HYPERTENSIONAHA.111.174425.CrossRefPubMed
16.
go back to reference Reynolds JA, Haque S, Berry JL, Pemberton P, Teh LS, Ho P, Gorodkin R, Bruce IN: 25-Hydroxyvitamin D deficiency is associated with increased aortic stiffness in patients with systemic lupus erythematosus. Rheumatology. 2012, 51: 544-551. 10.1093/rheumatology/ker352.PubMedCentralCrossRefPubMed Reynolds JA, Haque S, Berry JL, Pemberton P, Teh LS, Ho P, Gorodkin R, Bruce IN: 25-Hydroxyvitamin D deficiency is associated with increased aortic stiffness in patients with systemic lupus erythematosus. Rheumatology. 2012, 51: 544-551. 10.1093/rheumatology/ker352.PubMedCentralCrossRefPubMed
17.
go back to reference Scragg R, Holdaway I, Singh V, Metcalf P, Baker J, Dryson E: Serum 25-hydroxyvitamin D3 levels decreased in impaired glucose tolerance and diabetes mellitus. Diabetes Res Clin Pract. 1995, 27: 181-188. 10.1016/0168-8227(95)01040-K.CrossRefPubMed Scragg R, Holdaway I, Singh V, Metcalf P, Baker J, Dryson E: Serum 25-hydroxyvitamin D3 levels decreased in impaired glucose tolerance and diabetes mellitus. Diabetes Res Clin Pract. 1995, 27: 181-188. 10.1016/0168-8227(95)01040-K.CrossRefPubMed
18.
go back to reference Targher G, Bertolini L, Padovani R, Zenari L, Scala L, Cigolini M, Arcaro G: Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin Endocrinol. 2006, 65: 593-597. 10.1111/j.1365-2265.2006.02633.x.CrossRef Targher G, Bertolini L, Padovani R, Zenari L, Scala L, Cigolini M, Arcaro G: Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin Endocrinol. 2006, 65: 593-597. 10.1111/j.1365-2265.2006.02633.x.CrossRef
19.
go back to reference Borissova AM, Tankova T, Kirilov G, Dakovska L, Kovacheva R: The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in Type 2 diabetic patients. Int J Clin Pract. 2003, 57: 258-261.PubMed Borissova AM, Tankova T, Kirilov G, Dakovska L, Kovacheva R: The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in Type 2 diabetic patients. Int J Clin Pract. 2003, 57: 258-261.PubMed
20.
go back to reference Niederhoffer N, Lartaud-Idjouadiene I, Giummelly P, Duvivier C, Peslin R, Atkinson J: Calcification of medial elastic fibers and aortic elasticity. Hypertension. 1997, 29: 999-1006. 10.1161/01.HYP.29.4.999.CrossRefPubMed Niederhoffer N, Lartaud-Idjouadiene I, Giummelly P, Duvivier C, Peslin R, Atkinson J: Calcification of medial elastic fibers and aortic elasticity. Hypertension. 1997, 29: 999-1006. 10.1161/01.HYP.29.4.999.CrossRefPubMed
21.
go back to reference Fitch RM, Vergona R, Sullivan ME, Wang YX: Nitric oxide synthase inhibition increases aortic stiffness measured by pulse wave velocity in rats. Cardiovasc Res. 2001, 51: 351-358. 10.1016/S0008-6363(01)00299-1.CrossRefPubMed Fitch RM, Vergona R, Sullivan ME, Wang YX: Nitric oxide synthase inhibition increases aortic stiffness measured by pulse wave velocity in rats. Cardiovasc Res. 2001, 51: 351-358. 10.1016/S0008-6363(01)00299-1.CrossRefPubMed
22.
go back to reference Ng K, Hildreth CM, Phillips JK, Avolio AP: Aortic stiffness is associated with vascular calcification and remodeling in a chronic kidney disease rat model. Am J Physiol Renal Physiol. 2011, 300: 1431-1436. 10.1152/ajprenal.00079.2011.CrossRef Ng K, Hildreth CM, Phillips JK, Avolio AP: Aortic stiffness is associated with vascular calcification and remodeling in a chronic kidney disease rat model. Am J Physiol Renal Physiol. 2011, 300: 1431-1436. 10.1152/ajprenal.00079.2011.CrossRef
23.
go back to reference Wolffenbuttel BH, Boulanger CM, Crijns FR, Huijberts MS, Poitevin P, Swennen GN, Vasan S, Egan JJ, Ulrich P, Cerami A, Levy BI: Breakers of advanced glycation end products restore large artery properties in experimental diabetes. Proc Natl Acad Sci USA. 1998, 95: 4630-4634. 10.1073/pnas.95.8.4630.PubMedCentralCrossRefPubMed Wolffenbuttel BH, Boulanger CM, Crijns FR, Huijberts MS, Poitevin P, Swennen GN, Vasan S, Egan JJ, Ulrich P, Cerami A, Levy BI: Breakers of advanced glycation end products restore large artery properties in experimental diabetes. Proc Natl Acad Sci USA. 1998, 95: 4630-4634. 10.1073/pnas.95.8.4630.PubMedCentralCrossRefPubMed
24.
go back to reference Pieper GM: Enhanced, unaltered and impaired nitric oxide-mediated endothelium-dependent relaxation in experimental diabetes mellitus: importance of disease duration. Diabetologia. 1999, 42: 204-213. 10.1007/s001250051140.CrossRefPubMed Pieper GM: Enhanced, unaltered and impaired nitric oxide-mediated endothelium-dependent relaxation in experimental diabetes mellitus: importance of disease duration. Diabetologia. 1999, 42: 204-213. 10.1007/s001250051140.CrossRefPubMed
25.
go back to reference Resch M, Schmid P, Amann K, Fredersdorf S, Weil J, Schach C, Birner C, Griese DP, Kreuzer P, Brunner S, Luchner A, Riegger GA, Endemann DH: Eplerenone prevents salt-induced vascular stiffness in Zucker diabetic fatty rats: a preliminary report. Cardiovasc Diabetol. 2011, 10: 94-10.1186/1475-2840-10-94.PubMedCentralCrossRefPubMed Resch M, Schmid P, Amann K, Fredersdorf S, Weil J, Schach C, Birner C, Griese DP, Kreuzer P, Brunner S, Luchner A, Riegger GA, Endemann DH: Eplerenone prevents salt-induced vascular stiffness in Zucker diabetic fatty rats: a preliminary report. Cardiovasc Diabetol. 2011, 10: 94-10.1186/1475-2840-10-94.PubMedCentralCrossRefPubMed
26.
go back to reference Lu X, Guo X, Karathanasis SK, Zimmerman KM, Onyia JE, Peterson RG, Kassab GS: Rosiglitazone reverses endothelial dysfunction but not remodeling of femoral artery in Zucker diabetic fatty rats. Cardiovasc Diabetol. 2010, 9: 19-10.1186/1475-2840-9-19.PubMedCentralCrossRefPubMed Lu X, Guo X, Karathanasis SK, Zimmerman KM, Onyia JE, Peterson RG, Kassab GS: Rosiglitazone reverses endothelial dysfunction but not remodeling of femoral artery in Zucker diabetic fatty rats. Cardiovasc Diabetol. 2010, 9: 19-10.1186/1475-2840-9-19.PubMedCentralCrossRefPubMed
27.
go back to reference Giannattasio C, Failla M, Grappiolo A, Gamba PL, Paleari F, Mancia G: Progression of large artery structural and functional alterations in Type I diabetes. Diabetologia. 2001, 44: 203-208. 10.1007/s001250051600.CrossRefPubMed Giannattasio C, Failla M, Grappiolo A, Gamba PL, Paleari F, Mancia G: Progression of large artery structural and functional alterations in Type I diabetes. Diabetologia. 2001, 44: 203-208. 10.1007/s001250051600.CrossRefPubMed
28.
go back to reference Gómez-Marcos MA, Recio-Rodríguez JI, Patino-Alonso MC, Agudo-Conde C, Gómez-Sánchez L, Rodríguez-Sánchez E, Martín-Cantera C, García-Ortiz L: Relationship between intima-media thickness of the common carotid artery and arterial stiffness in subjects with and without type 2 diabetes: a case-series report. Cardiovasc Diabetol. 2011, 10: 3-10.1186/1475-2840-10-3.PubMedCentralCrossRefPubMed Gómez-Marcos MA, Recio-Rodríguez JI, Patino-Alonso MC, Agudo-Conde C, Gómez-Sánchez L, Rodríguez-Sánchez E, Martín-Cantera C, García-Ortiz L: Relationship between intima-media thickness of the common carotid artery and arterial stiffness in subjects with and without type 2 diabetes: a case-series report. Cardiovasc Diabetol. 2011, 10: 3-10.1186/1475-2840-10-3.PubMedCentralCrossRefPubMed
29.
go back to reference Asmar R, Benetos A, Topouchian J, Laurent P, Pannier B, Brisac AM, Target R, Levy BI: Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension. 1995, 26: 485-490. 10.1161/01.HYP.26.3.485.CrossRefPubMed Asmar R, Benetos A, Topouchian J, Laurent P, Pannier B, Brisac AM, Target R, Levy BI: Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension. 1995, 26: 485-490. 10.1161/01.HYP.26.3.485.CrossRefPubMed
30.
go back to reference Fiordaliso F, Cuccovillo I, Bianchi R, Bai A, Doni M, Salio M, De Angelis N, Ghezzi P, Latini R, Masson S: Cardiovascular oxidative stress is reduced by an ACE inhibitor in a rat model of streptozotocin-induced diabetes. Life Sci. 2006, 79: 121-129. 10.1016/j.lfs.2005.12.036.CrossRefPubMed Fiordaliso F, Cuccovillo I, Bianchi R, Bai A, Doni M, Salio M, De Angelis N, Ghezzi P, Latini R, Masson S: Cardiovascular oxidative stress is reduced by an ACE inhibitor in a rat model of streptozotocin-induced diabetes. Life Sci. 2006, 79: 121-129. 10.1016/j.lfs.2005.12.036.CrossRefPubMed
31.
go back to reference Armentano RL, Levenson J, Barra JG, Fischer EI, Breitbart GJ, Pichel RH, Simon A: Assessment of elastin and collagen contribution to aortic elasticity in conscious dogs. Am J Physiol. 1991, 260: 1870-1877. Armentano RL, Levenson J, Barra JG, Fischer EI, Breitbart GJ, Pichel RH, Simon A: Assessment of elastin and collagen contribution to aortic elasticity in conscious dogs. Am J Physiol. 1991, 260: 1870-1877.
32.
go back to reference Shadwick RE: Mechanical design in arteries. J Exp Biol. 1999, 202: 3305-3313.PubMed Shadwick RE: Mechanical design in arteries. J Exp Biol. 1999, 202: 3305-3313.PubMed
33.
go back to reference Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA: Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation. 1993, 88: 2510-2516. 10.1161/01.CIR.88.6.2510.CrossRefPubMed Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA: Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation. 1993, 88: 2510-2516. 10.1161/01.CIR.88.6.2510.CrossRefPubMed
34.
go back to reference Wallace SM, Yasmin , McEniery CM, Mäki-Petäjä KM, Booth AD, Cockcroft JR, Wilkinson IB: Isolated systolic hypertension is characterized by increased aortic stiffness and endothelial dysfunction. Hypertension. 2007, 50: 228-233. 10.1161/HYPERTENSIONAHA.107.089391.CrossRefPubMed Wallace SM, Yasmin , McEniery CM, Mäki-Petäjä KM, Booth AD, Cockcroft JR, Wilkinson IB: Isolated systolic hypertension is characterized by increased aortic stiffness and endothelial dysfunction. Hypertension. 2007, 50: 228-233. 10.1161/HYPERTENSIONAHA.107.089391.CrossRefPubMed
35.
go back to reference Xiong Y, Lei M, Fu S, Fu Y: Effect of diabetic duration on serum concentrations of endogenous inhibitor of nitric oxide synthase in patients and rats with diabetes. Life Sci. 2005, 77: 149-159. 10.1016/j.lfs.2004.10.062.CrossRefPubMed Xiong Y, Lei M, Fu S, Fu Y: Effect of diabetic duration on serum concentrations of endogenous inhibitor of nitric oxide synthase in patients and rats with diabetes. Life Sci. 2005, 77: 149-159. 10.1016/j.lfs.2004.10.062.CrossRefPubMed
36.
go back to reference Serizawa K, Yogo K, Aizawa K, Tashiro Y, Ishizuka N: Nicorandil prevents endothelial dysfunction due to antioxidative effects via normalisation of NADPH oxidase and nitric oxide synthase in streptozotocin diabetic rats. Cardiovasc Diabetol. 2011, 10: 105-10.1186/1475-2840-10-105.PubMedCentralCrossRefPubMed Serizawa K, Yogo K, Aizawa K, Tashiro Y, Ishizuka N: Nicorandil prevents endothelial dysfunction due to antioxidative effects via normalisation of NADPH oxidase and nitric oxide synthase in streptozotocin diabetic rats. Cardiovasc Diabetol. 2011, 10: 105-10.1186/1475-2840-10-105.PubMedCentralCrossRefPubMed
37.
go back to reference Altinova AE, Arslan M, Sepici-Dincel A, Akturk M, Altan N, Toruner FB: Uncomplicated type 1 diabetes is associated with increased asymmetric dimethylarginine concentrations. J Clin Endocrinol Metab. 2007, 92: 1881-1885. 10.1210/jc.2006-2643.CrossRefPubMed Altinova AE, Arslan M, Sepici-Dincel A, Akturk M, Altan N, Toruner FB: Uncomplicated type 1 diabetes is associated with increased asymmetric dimethylarginine concentrations. J Clin Endocrinol Metab. 2007, 92: 1881-1885. 10.1210/jc.2006-2643.CrossRefPubMed
38.
go back to reference Wong MS, Delansorne R, Man RY, Svenningsen P, Vanhoutte PM: Chronic treatment with vitamin D lowers arterial blood pressure and reduces endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol. 2010, 299: 1226-1234. 10.1152/ajpheart.00288.2010.CrossRef Wong MS, Delansorne R, Man RY, Svenningsen P, Vanhoutte PM: Chronic treatment with vitamin D lowers arterial blood pressure and reduces endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol. 2010, 299: 1226-1234. 10.1152/ajpheart.00288.2010.CrossRef
39.
go back to reference Dong Y, Stallmann-Jorgensen IS, Pollock NK, Harris RA, Keeton D, Huang Y, Li K, Bassali R, Guo DH, Thomas J, Pierce GL, White J, Holick MF, Zhu H: A 16-week randomized clinical trial of 2000 international units daily vitamin D3 supplementation in black youth: 25-hydroxyvitamin D, adiposity, and arterial stiffness. J Clin Endocrinol Metab. 2010, 95: 4584-4591. 10.1210/jc.2010-0606.CrossRefPubMed Dong Y, Stallmann-Jorgensen IS, Pollock NK, Harris RA, Keeton D, Huang Y, Li K, Bassali R, Guo DH, Thomas J, Pierce GL, White J, Holick MF, Zhu H: A 16-week randomized clinical trial of 2000 international units daily vitamin D3 supplementation in black youth: 25-hydroxyvitamin D, adiposity, and arterial stiffness. J Clin Endocrinol Metab. 2010, 95: 4584-4591. 10.1210/jc.2010-0606.CrossRefPubMed
40.
go back to reference Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP: 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002, 110: 229-238.PubMedCentralCrossRefPubMed Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP: 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002, 110: 229-238.PubMedCentralCrossRefPubMed
41.
go back to reference Levy BI, Benessiano J, Henrion D, Caputo L, Heymes C, Duriez M, Poitevin P, Samuel JL: Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. J Clin Invest. 1996, 98: 418-425. 10.1172/JCI118807.PubMedCentralCrossRefPubMed Levy BI, Benessiano J, Henrion D, Caputo L, Heymes C, Duriez M, Poitevin P, Samuel JL: Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. J Clin Invest. 1996, 98: 418-425. 10.1172/JCI118807.PubMedCentralCrossRefPubMed
42.
go back to reference Albaladejo P, Bouaziz H, Duriez M, Gohlke P, Levy BI, Safar ME, Benetos A: Angiotensin converting enzyme inhibition prevents the increase in aortic collagen in rats. Hypertension. 1994, 23: 74-82. 10.1161/01.HYP.23.1.74.CrossRefPubMed Albaladejo P, Bouaziz H, Duriez M, Gohlke P, Levy BI, Safar ME, Benetos A: Angiotensin converting enzyme inhibition prevents the increase in aortic collagen in rats. Hypertension. 1994, 23: 74-82. 10.1161/01.HYP.23.1.74.CrossRefPubMed
Metadata
Title
Effect of vitamin D on aortic remodeling in streptozotocin-induced diabetes
Authors
Erik Salum
Priit Kampus
Mihkel Zilmer
Jaan Eha
Mark Butlin
Alberto P Avolio
Taavi Põdramägi
Andres Arend
Marina Aunapuu
Jaak Kals
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2012
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-11-58

Other articles of this Issue 1/2012

Cardiovascular Diabetology 1/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.